EyeArt™ combines automated image analysis tools with a user-friendly telemedicine/cloud-based interface to address the need for faster screening of more diabetic patients, and at the same time provide eye care professionals with greater confidence in finding the right patients.
Characteristics / Facts:
AUTOMATIC DIABETIC RETINOPATHY DETECTION AND GRADING PLATFORM (DR)
EyeArt™ is a fully automated, CE marked DR screening software.
EyeArt™ is an Artificial Intelligence software platform featuring cutting–edge image analysis and classification technologies.
Fundus images of both eyes, which have been captured by EyeArt™ compatible cameras, are uploaded to the secure cloud-based platform for processing.
EyeArt™ automatically analyzes the images and returns the result in less than 60 sec.
EyeArt™ report contains positive/negative DR screening outcome, clear indication of image quality, DR severity level, and retinal images.
EyeArt™ streamlines and simplifies DR screening/grading programs while greatly increasing accuracy and consistency of clinical outcomes.
EyeArt™ allows ALL health-care professionals to automatically perform real-time DR screening in one visit.
EyeArt™ demonstrated 91% sensitivity at 91% specificity as compared to expert human graders on over 100K patient visits.
EyeArt™ enables imaging, grading DR as per internationally recognized standards, and reporting in a single office visit for a patient.
The EyeArt™ technology enables scalable, very high volume screening programs with all the inherent benefits of the most sophisticated telemedicine programs.
EyeArt™ makes setting-up of DR screening program easy and cost effective.